These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19585650)

  • 1. A call for attention and trials on hepatitis B e antigen-negative, alanine aminotransferase-normal chronic hepatitis B virus infection.
    Zhao H; Miao R
    Hepatology; 2009 Aug; 50(2):658; author reply 658-9. PubMed ID: 19585650
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.
    Dai CY; Chuang WL; Huang JF; Yu ML
    Hepatology; 2009 Feb; 49(2):704-5; author reply 705-6. PubMed ID: 19177587
    [No Abstract]   [Full Text] [Related]  

  • 3. Should antiviral treatment be extended to patients with chronic hepatitis B and mildly elevated alanine aminotransferase?
    Lok AS
    Hepatology; 2010 Apr; 51(4):1107-9. PubMed ID: 20162620
    [No Abstract]   [Full Text] [Related]  

  • 4. Changing landscape of antiviral resistance management in chronic hepatitis B.
    Nguyen T; Locarnini S; Desmond P
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1314-7. PubMed ID: 18853991
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral antivirals for chronic hepatitis B.
    Min AD; Dienstag JL
    Clin Liver Dis; 2007 Nov; 11(4):851-68, ix. PubMed ID: 17981232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To "be" or not to "be": that is the question.
    Frenette CT; Gish RG
    Am J Gastroenterol; 2009 Aug; 104(8):1948-52. PubMed ID: 19661938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral therapy in HBe-Ag-positive hepatitis B with normal aminotransferase levels.
    Geier A; Dietrich CG; Gartung C
    Hepatology; 2003 Mar; 37(3):712-3; author reply 713. PubMed ID: 12601370
    [No Abstract]   [Full Text] [Related]  

  • 8. [Predictors for virologic response in management of chronic hepatitis B].
    Lee JM; Ahn SH
    Korean J Hepatol; 2010 Mar; 16(1):1-4. PubMed ID: 20375637
    [No Abstract]   [Full Text] [Related]  

  • 9. The Use of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase.
    Lo GH
    Gastroenterology; 2014 Sep; 147(3):718-9. PubMed ID: 25075941
    [No Abstract]   [Full Text] [Related]  

  • 10. [Entecavir. Treatment of chronic hepatitis b virus infections].
    Musch A
    Med Monatsschr Pharm; 2006 Nov; 29(11):392-6. PubMed ID: 17131685
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiviral therapy for chronic hepatitis B: are we doing any good to patients?
    Wong VW; Sung JJ
    J Antimicrob Chemother; 2009 Aug; 64(2):223-6. PubMed ID: 19468026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of chronic hepatitis B].
    Mauss S
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():48-51. PubMed ID: 19031564
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G; Villanova N; Amed MA; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
    J Chemother; 1989 Jul; 1(4 Suppl):1094-5. PubMed ID: 16312786
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma.
    Geier A; Gartung C; Dietrich CG
    N Engl J Med; 2002 Nov; 347(21):1721-2; author reply 1721-2. PubMed ID: 12444194
    [No Abstract]   [Full Text] [Related]  

  • 15. Viral load in hepatitis B e antigen-negative carriers with normal aminotransferase level.
    Liaw YF
    Hepatology; 2007 Sep; 46(3):947; author reply 947-9. PubMed ID: 17705263
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on hepatitis B treatment.
    Firpi RJ; Martin P
    MedGenMed; 2002 Sep; 4(3):9. PubMed ID: 12466752
    [No Abstract]   [Full Text] [Related]  

  • 17. Five-year results of chronic hepatitis B infection treatment in children with cured cancer.
    Saltik-Temizel IN; Demir H; Usta Y; Gürakan F; Ozen H; Yüce A
    Liver Int; 2006 Dec; 26(10):1298-9. PubMed ID: 17105598
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
    Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
    Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBV Chronic hepatitis during chemotherapy - an immune controlled disease.
    Caruntu FA; Gheorghita V
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):445-9. PubMed ID: 19104707
    [No Abstract]   [Full Text] [Related]  

  • 20. [The clinic features and the short-term efficacy of entecavir treatment of the HBeAG negative acute-on-chronic hepatitis B liver failure].
    Shu X; Xu QH; Chen N; Zhang K; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):481-3. PubMed ID: 19544652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.